The sobering statistics are ones that Jim Michel, 64, understands all too well. The co-founder and Chairman of Inventus was diagnosed with a benign brain tumour in 2018. In recent months, following ...

Basecamp Research has launched a new scientific initiative, called the Trillion Gene Atlas, to bring together genomic data ...

The aligned pathway for UK drugs regulator MHRA and reimbursement authority NICE – aimed at slashing the time it takes for ...

An appeals court in the US has said that AbbVie, AstraZeneca, Novartis, and Sanofi will have to defend claims they defrauded ...

Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment for plaque psoriasis. The US regulator has approved icotrokinra under the ...

Over the past decade, pharma has made digital health a strategic priority, launching patient apps, HCP platforms, adherence tools, and data-driven services. Yet, outcomes remain mixed. Many ...

Ask a pharma commercial team where lung cancer patients are treated in France and most will point to major academic centres such as Gustave Roussy, Institut Curie, or the Assistance Publique network ...

A phase 2 trial has shown promising protective efficacy for what could become the first vaccine against hookworm, a parasitic disease affecting hundreds of millions of people around the world. The ...

This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...

In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at ...

Roche has ramped up its investment in NVIDIA's AI chips, launching an upscaled hybrid-cloud AI factory that it believes is ...

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage ...